{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "CHEMIOTERAPIA DEI TUMORI CEREBRALI METASTATICI: VALUTAZIONE DELL' EFFICACIA TERAPEUTICA E DEGLI EFFETTI COLLATERALI; CHIMIOTHERAPIE DES TUMEURS CEREBRALES METASTATIQUES. EVALUATION DE L'EFFICACITE THERAPEUTIQUE ET DES EFFETS COLLATERAUX",
    "dc:creator": [
        "DI BENEDETTO G",
        "PERRIA C",
        "PUPPO F",
        "PRIOLO C",
        "SOLDA AM",
        "INDIVERI F"
    ],
    "dc:date": "1978",
    "dc:type": "Article",
    "dc:language": "Italian",
    "dc:format": "ATTI ACCAD. MED. LOMBARDA; ITA; DA. 1978; VOL. 33; NO 1; PP. 113-122; BIBL. 37 REF.",
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "TUMEUR"
        },
        {
            "@xml:lang": "fr",
            "#text": "INTRACRANIEN"
        },
        {
            "@xml:lang": "fr",
            "#text": "METASTATIQUE"
        },
        {
            "@xml:lang": "fr",
            "#text": "POLYCHIMIOTHERAPIE"
        },
        {
            "@xml:lang": "fr",
            "#text": "ANTICANCEREUX"
        },
        {
            "@xml:lang": "fr",
            "#text": "ANTIBIOTIQUE"
        },
        {
            "@xml:lang": "fr",
            "#text": "AGENT ALKYLANT"
        },
        {
            "@xml:lang": "fr",
            "#text": "ANTIMETABOLITE"
        },
        {
            "@xml:lang": "fr",
            "#text": "ORIGINE VEGETALE"
        },
        {
            "@xml:lang": "fr",
            "#text": "EFFICACITE TRAITEMENT"
        },
        {
            "@xml:lang": "fr",
            "#text": "EFFET SECONDAIRE"
        },
        {
            "@xml:lang": "fr",
            "#text": "HOMME"
        },
        {
            "@xml:lang": "fr",
            "#text": "TRAITEMENT"
        },
        {
            "@xml:lang": "fr",
            "#text": "CHIMIOTHERAPIE"
        },
        {
            "@xml:lang": "fr",
            "#text": "SYSTEME NERVEUX PATHOLOGIE"
        },
        {
            "@xml:lang": "fr",
            "#text": "DOXORUBICINE"
        },
        {
            "@xml:lang": "fr",
            "#text": "CARMUSTINE"
        },
        {
            "@xml:lang": "fr",
            "#text": "CYCLOPHOSPHAMIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "FLUOROURACILE"
        },
        {
            "@xml:lang": "fr",
            "#text": "TEMPOSIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "ANTHRACYCLINE DERIVE"
        },
        {
            "@xml:lang": "fr",
            "#text": "PHARMACOLOGIE"
        },
        {
            "@xml:lang": "en",
            "#text": "TUMOR"
        },
        {
            "@xml:lang": "en",
            "#text": "INTRACRANIAL"
        },
        {
            "@xml:lang": "en",
            "#text": "METASTATIC"
        },
        {
            "@xml:lang": "en",
            "#text": "POLYCHEMOTHERAPY"
        },
        {
            "@xml:lang": "en",
            "#text": "ANTINEOPLASTIC AGENT"
        },
        {
            "@xml:lang": "en",
            "#text": "ANTIBIOTIC"
        },
        {
            "@xml:lang": "en",
            "#text": "ALKYLATING AGENT"
        },
        {
            "@xml:lang": "en",
            "#text": "ANTIMETABOLIC"
        },
        {
            "@xml:lang": "en",
            "#text": "PLANT ORIGIN"
        },
        {
            "@xml:lang": "en",
            "#text": "THERAPEUTIC EFFICIENCY"
        },
        {
            "@xml:lang": "en",
            "#text": "SECONDARY EFFECT"
        },
        {
            "@xml:lang": "en",
            "#text": "HUMAN"
        },
        {
            "@xml:lang": "en",
            "#text": "TREATMENT"
        },
        {
            "@xml:lang": "en",
            "#text": "CHEMOTHERAPY"
        },
        {
            "@xml:lang": "en",
            "#text": "NERVOUS SYSTEM DISEASES"
        },
        {
            "@xml:lang": "en",
            "#text": "PHARMACOLOGY"
        },
        "002B02: Pharmacologie. Traitements medicamenteux / Pharmacology. Drug treatments"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number PASCAL8050436134"
}